generic glp 1 fda approved approves GLP-1 medication Victoza (liraglutide) This Week in GLP-1: Apotex

It May Be for the Short Term Noom doesnt necessarily frown upon people starting and stopping its microdosing program, including losing weight for a wedding or a vacation, Egler says

PsA Disease Activity Improves on GLP-1s A retrospective study presented at ACR Convergence 2025, led by researchers from the University of Toronto and NYU, followed 48 patients with psoriatic arthritis who started GLP-1 receptor agonists. The findings: Significant weight loss (35% of patients lost 510% of body weight

Int J Clin Exp Pathol

The company continues to invest in pharmaceuticals, particularly in oncology and immunology, and medical devices

Trust and Transparency Noom is one of the most recognized names in digital weight loss

55,56 These findings prompted regulatory safety communications and heightened surveillance regarding pancreatic safety